Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Vet groups warn CMA remedies could cause welfare issues
The vet groups raised concerns over remedies including longer prescription periods and the use of generic medicines.
BVA and others set out possible unintended consequences.

A coalition of veterinary groups has warned that unintended consequences from the ongoing review into the veterinary sector by the Competition and Markets Authority (CMA) could lead to animal welfare issues.

The British Veterinary Association (BVA), the British Small Animal Veterinary Association (BSAVA), the Society of Practising Veterinary Surgeons (SPVS) and the Veterinary Management Group (VMG) set out their concerns in their response to the CMA's consultation on its issues statement.

The CMA's issues statement listed the Inquiry Group's initial theories about issues surrounding competition in the veterinary sector and potential remedies.

In their joint response, which they have made public, the veterinary groups set out a number of areas where they believe the CMA's proposed remedies could have unintended negative impacts.

The groups state that they have significant concerns about the idea of mandating longer prescriptions periods. They warn it could cause a serious threat to animal welfare issues by possibly leading to antimicrobial resistance, side effects going unmonitored, and conditions worsening without being seen.

They also argue that the proposal that veterinary practices should send annual 'wake-up' letters to clients to prompt them to reconsider their choice of practice could undermine the vet-client-patient relationship and continuity of care. This could increase the risks posed by miscommunication, lack of comprehensive medical records, and fragmented care.

On the topic of generic medicines, the groups have reminded the CMA that veterinary surgeons must follow the Veterinary Medicines Regulations and prescribe according to the Cascade. Suggesting that unlicensed generic medication is equivalent to licensed veterinary products would be irresponsible, the groups say.

Anna Judson, BVA president, said: “Cleary these are unintended consequences, but they do highlight the importance of continued engagement between the CMA and the profession as the investigation progresses to ensure the veterinary voice is heard and unintended consequences are avoided.”

The full response can be read here.

Image © Shutterstock

Become a member or log in to add this story to your CPD history

Defra shares new Sanitary and Phytosanitary guidance

News Story 1
 Defra has published guidance for the vet sector ahead of a proposed UK-EU Sanitary and Phytosanitary agreement.

The agreement, which will change the movement and trade of animals and related products, could see reductions in checks, paperwork and certification. As well as describing regulatory developments, the advice highlights the importance of animal ID, registration and traceability in disease control and other compliance arrangements.

The guidance can be found here. More detail is expected as negotiations progress. 

Click here for more...
News Shorts
Lords Committee opens Pet Parasite Medication inquiry

The House of Lords Environment and Climate Change Committee will launch its inquiry into Pet Parasite Medication (PPM) on Wednesday (3 June).

Focusing on treatments containing fipronil and imidacloprid, the inquiry will seek to understand distribution pathways and the impacts of PPM use and non-use on biodiversity and human health. It will also cover current regulation, monitoring, and the potential implications for pets and their owners.

The committee will hear evidence from environmental non-governmental organisations and research institutes. The public can follow the proceedings live on Parliament TV or in person in the Palace of Westminster.